Trial intelligence / Profile preview

Human albumin versus Ringer-lactate and coagulation competence during elective cystectomy

2013-005350-29Phase 4Completed

Sponsor
Rigshospitalet
Start
Feb 2014
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised trial of albumin (human) in abnormal coagulation profile and coagulation and blood loss (2 arms), sponsored by Rigshospitalet. Primary endpoint: Coagulation competence. Started Feb 2014; status: completed.

02

Drugs

albumin (human)
03

Conditions

abnormal coagulation profilecoagulation and blood loss

Beyond the preview

Go deeper on 2013-005350-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-005350-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call